1352805-40-3

Upstream product

• 1352805-39-0 tert-butyl {1-[3-chloro-1-(3-fluorophenyl)-1H-indol-2-yl]ethyl}carbamate 
• 1352805-38-9 tert-butyl {1-[1-(3-fluorophenyl)-1H-indol-2-yl]ethyl}carbamate 
• 1352805-37-8 1-[1-(3-fluorophenyl)-1H-indol-2-yl]ethanamine 
• 1352805-36-7 2-(1-azidoethyl)-1-(3-fluorophenyl)-1H-indole 
• 1352805-35-6 1-[1-(3-fluorophenyl)-1H-indol-2-yl]ethanol 
• 1352805-34-5 1-[1-(3-fluorophenyl)-1H-indol-2-yl]ethanone 
• 1352805-33-4 1-(3-fluorophenyl)-N-methoxy-N-methyl-1H-indole-2-carboxamide 
• 156571-69-6 N-methoxy-N-methyl-1H-indole-2-carboxamide 
• 1477-50-5 Indole-2-carboxylic acid 

Relevant academic research and scientific papers

FUSED PYRROLE DERIVATIVES AS PI3K INHIBITORS

The present invention provides fused pyrrole derivatives of Formula I: wherein V, W, X, Y, L, Q, Ar, Z, R1 and R6 are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.